Evidence map›Paper›PMID 23637975›Full record

ArticlePloS one2013

Microsporidia and its relation to Crohn's disease. A retrospective study.

Juan C Andreu-Ballester, Carlos Garcia-Ballesteros, Victoria Amigo, Ferran Ballester, Rafael Gil-Borrás, Ignacio Catalán-Serra, Angela Magnet, Soledad Fenoy, Carmen del Aguila, Jose Ferrando-Marco and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Prevalence of Anti-Pathogens (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. High Prevalence of Microsporidia in the North African Hedgehog (Animals : an open access journal from MDPI · 2023
    Article
  10. Article
  11. Article
  12. Microsporidia as a Potential Threat to the Iberian Lynx (Animals : an open access journal from MDPI · 2022
    Article
  13. Human microsporidian pathogenJournal of cell science · 2021
    Article
  14. Frontiers in medicine · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Juan C Andreu-BallesterResearch Department, Arnau de Vilanova Hospital, Valencia, Spain.
Carlos Garcia-Ballesteros
Victoria Amigo
Ferran Ballester
Rafael Gil-Borrás
Ignacio Catalán-Serra
Angela Magnet
Soledad Fenoy
Carmen del Aguila
Jose Ferrando-Marco
Carmen Cuéllar
Hospital Arnau de Vilanova · ESUniversidad San Pablo CEU · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe cause of Crohn's Disease (CD) remains unknown. Recently a decrease in the global lymphocyte population in the peripheral blood of CD patients has been reported. This decrease was more evident in γδ T lymphocytes, especially γδ CD8+T subsets. Furthermore, a decrease of IL-7 was also observed in these patients. We propose the hypothesis that microsporidia, an obligate intracellular opportunistic parasite recently related to fungi, in CD patients can take advantage of the lymphocytes and IL-7 deficits to proliferate and to contribute to the pathophysiology of this disease. METHODS AND

findingsIn this case-control study, serum samples were collected from 36 CD patients and from 36 healthy individuals (controls), IgE and IgG anti-Encephalitozoon antibodies were determined by ELISA; and forty-four intestinal tissue samples were analyzed through real time Polymerase Chain Reaction (PCR), twenty CD patients, nine with others diseases and 15 healthy subjects. We observed that IgE anti-Encephalitozoon levels were significantly higher in patients with CD: 0.386(±0.256) vs control group, 0.201(±0.147), P<0.001. However, IgG anti-Encephalitozoon values were significantly lower in CD patients: 0.361(±0.256) vs control group, 0.876(±0.380), P<0.001. In the group of CD patients, 6/20 (30%) were positive by real time PCR for microsporidia and, all the patients of the control group were negative by real time PCR.

conclusionsThese results suggest that CD patients are a group at risk for microsporidiasis and, moreover that microsporidia may be involved as a possible etiologic factor of CD.

Indexed as

Case-Control StudiesCrohn DiseaseEncephalitozoonHumansImmunoglobulin EMicrosporidiaReal-Time Polymerase Chain ReactionRetrospective StudiesT-Lymphocyte SubsetsImmunoglobulin E

Identifiers

PMID23637975
PMCPMC3630148
OpenAlexW2068300471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.